Login / Signup

Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.

Caterina VizzardelliM GindlS RoosChristian MöbsB NaglF ZimmannV SexlL KennerA NeunkirchnerG J ZlabingerW F PicklW PfütznerBarbara Bohle
Published in: Allergy (2017)
Our data demonstrate that post-AIT sera with IgE-blocking activity ameliorate allergic airway inflammation in a human/mouse chimeric model of respiratory allergy independently of AIT-induced cellular changes.
Keyphrases